Most people can get right back to their day after the treatment is over, without any side effects or post-treatment problems
No FDA-approved KPV drug exists
Amgen's MariTide Phase 2 showed no weight loss plateau at 52 weeks (Nov 2024): The absence of a weight loss plateau effect which both semaglutide and tirzepatide display would be a clinically meaningful differentiation if confirmed in Phase 3, potentially enabling greater sustained weight loss
Building on COVID-19 pandemic-era successes, scientists tested mRNA vaccines for illnesses like the flu, HIV, and certain cancers
High-Dose Vitamin C: Your Immune System's Most Powerful Ally Given intravenously, Vitamin C reaches blood concentrations you can't get from oral supplements
Certain groups face higher risk, including older adults, vegans, those with pernicious anaemia, and people taking medications such as metformin or proton pump inhibitors